About the vaccines

Tribune News Service

Updated At : 11:33 AM Jan 04, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

About the vaccines

n Covishield (two dose) is a recombinant chimpanzee adenovirus vector vaccine with safety, immunogenicity and efficacy data available from 23,745 participants aged 18 and above from overseas clinical studies. Overall efficacy is 70.42 per cent

n Covaxin (twin dose): Bharat Biotech’s whole virion inactivated coronavirus vaccine (Covaxin) is based on vero cell platform, which has well established track record of safety and efficacy

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles